DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

01349 FUDANZHANGJIANG

Trading Add to Porfolio
Index Constituent : None
Major Shareholders [02607] Shanghai Pharmaceuticals Holding Co., Ltd. (20.27%)
China New Enterprise Investment Fund II (15.14%)
Yang Zong Meng (6.52%)
Wang Hai Bo (5.41%)		 Sector Health Care & Biotechnology
Web Site http://www.fd-zj.com Tel (86 21) 5895-3355
Email fd-zj@fd-zj.com Fax (86 21) 5855-3990
Related Equities N/A
Principal Activities The Group is principally engaged in the research, development and selling of self-developed biopharmaceutical know-how, carrying out contracted research for customers, manufacturing and selling of medical products and providing other medical services in the PRC.

Consolidated List of Substantial Shareholders

Name Number of Shares Interested % of Issued Share Capital (%) Date of Last Notice Filed (Y/M/D)
Invesco Hong Kong Limited 25,236,000(L)  7.42(L)  26/01/2018
Last Update : 2019-02-28
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool

Complete List of Directors

Director's Name Number of Shares Interested % of issued share capital (%) Date of Last Notice Filed (Y/M/D)
Last Update : 2019-02-28
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Back to Top